1.Pill induced esophagitis.
Sung Hee JUNG ; Hyeon Woong YANG ; Mi Kyoung LIM
Korean Journal of Medicine 2007;72(1):111-112
No abstract available.
Esophagitis*
2.The Weaning Method of inhaled Nitric Oxide.
Hyun Woo LEE ; Jae Woong LEE ; Sung Yeul HYUN ; Ha Chang LEE ; Chul Hyun PARK ; Kook Yang PARK ; Hyeon Su YOO ; Kyung Cheon LEE ; Young Jin JANG
Journal of the Korean Pediatric Society 2001;44(4):413-417
PURPOSE: inhaled nitric oxide(iNO) is an excellent method for the postoperative pulmonary hypertension in congenital heart disease. But more detailed care is needed because of the development of rebound pulmonary hypertension after NO Withdrawal. We performed this study in order to discontinue the iNO successfully by way of presenting the adequate weaning and supplying methods. METHODS: Between January, 1998 and August, 1999 we sudied 10 patients who had rebound pulmonary hypertension(RPH) after iNO withdrawal. We completed the iNO in these patween the first the second trial of the weaning process. We tried to discover the differences between the first and second weaning process. We measured NO concentration at the start and just before NO withdrawal and during the period of weaning process. Moreover, to identify the iNO effects during the weaning of the iNO, we counted the degree of the change of PaO2/FiO2and mean PAP/SAP beween initial and at half of the initial NO concentration. RESULTS: Second weaning had a longer duration weaning process(11+/-0 cersus 5+/- hours, P<0.05), lower NO concentration just before NO withdrawal(2+/-.6 versus 4+/-ppm, P<0.05). In the change of the mean PAP/SAP and PaO2/FiO2as iNO was weaning from the initial iNO concentration to a half of the initial iNO concentration, the degree of increase in mean PAP/SAP(0.026+/-.07 versus 0.054+/-.07, P<0.05) and the degree of decrease in PaO2/FiO2(49+/-4 versus 65+/-2, P<0.05) were smaller in the second in the second weaning process than the first weaning process. CONCLUSION: A successful weaning of iNO can be performed with a low iNO concentration at the start and just before withdrawal and with the long duration iNO weaning process. Moreover, We speculate that the degree of change in the mean PAP/SAP and PaO2/FiO2at the half of the iNO weaning process are an indicator for the development of RPH.
Heart Defects, Congenital
;
Humans
;
Hypertension, Pulmonary
;
Nitric Oxide*
;
Weaning*
3.Are age, anthropometry and components of metabolic syndrome-risk factors interrelated with lower urinary tract symptoms in patients with erectile dysfunction? A prospective study.
Jae-Seung PAICK ; Ji-Hyun YANG ; Soo-Woong KIM ; Ja-Hyeon KU
Asian Journal of Andrology 2007;9(2):213-220
AIMTo evaluate the effects of metabolic profiles on lower urinary tract symptoms (LUTS) in men with erectile dysfunction (ED).
METHODSA total of 75 impotent men aged 25-75 years old (mean 58.1 years) were included in the study on a prospective basis. Patients were evaluated with a complete history, physical examination, anthropometry and metabolic profiles. LUTS were assessed using the International Prostate Symptom Score (IPSS).
RESULTSOverall, there was no correlation between the IPSS and continuous parameters. However, when continuous variables were categorized, some parameters were significantly associated with LUTS. Patients with triglyceride level of 150 mg/dL or higher had more severe symptoms than those with triglyceride levels less than 150 mg/dL (19.4 +/- 2.4 vs. 14.3 +/- 1.1, P = 0.033). When 40 mg/dL was chosen as the high-density lipoprotein (HDL)-cholesterol cut-off level, the IPSS was significantly different between the two groups divided by 40 mg/dL (19.4 +/- 2.6 for HDL-cholesterol < 40 mg/dL vs. 14.4 +/- 1.0 for HDL-cholesterol = or > 40 mg/dL, P = 0.042). The area under the receiver operating characteristic curve (AUROCC) of triglyceride was 65.7% (95% confidence interval [CI], 52.6%-82.3%; P = 0.034) for severe LUTS. However, the AUROCC for 'HDL-cholesterol' was not significant (area, 65.4%; 95% CI, 48.2%-82.7%; P = 0.062). No other factors were determined to be significant in this regard.
CONCLUSIONThe results of the present study indicate that some metabolic profiles might influence LUTS in men with ED.
Adult ; Aged ; Aging ; Body Mass Index ; Erectile Dysfunction ; etiology ; pathology ; physiopathology ; Humans ; Male ; Metabolic Syndrome ; etiology ; Middle Aged ; Prostate ; pathology ; Risk Factors ; Triglycerides ; blood ; Urologic Diseases ; etiology ; pathology ; physiopathology
4.Acute Drug-Induced Hepatitis Caused by Albendazole.
Gi Young CHOI ; Hyeon Woong YANG ; Soung Hoon CHO ; Dong Wook KANG ; Hoon GO ; Woong Chul LEE ; Yun Jung LEE ; Sung Hee JUNG ; An Na KIM ; Sang Woo CHA
Journal of Korean Medical Science 2008;23(5):903-905
Albendazole binds to parasite's tubulin inhibiting its glucose absorption. Its common adverse effects are nausea, vomiting, constipation, thirst, dizziness, headache, hair loss and pruritus. Although mainly metabolized in the liver, abnormal liver function tests were a rare adverse effect during clinical trials and we found no literature about albendazole-induced hepatitis requiring admission. This patient had a previous history of albendazole ingestion in 2002 resulting in increase of liver function tests. And in 2005, the episode repeated. We evaluated the patient for viral hepatitis, alcoholic liver disease, and autoimmune hepatitis, but no other cause of hepatic injury could be found. Liver biopsy showed periportal steatosis and periportal necrosis. The initial abnormal liver function test improved only with supportive care. These findings and the Roussel Uclaf Causality Assessment Method of the Council for International Organizations of Medical Sciences (RUCAM/CIOMS) score of 9 are compatible with drug-induced hepatitis so we report the case of this patient with a review of the literature.
Albendazole/*adverse effects
;
Antiprotozoal Agents/*adverse effects
;
Eosinophils/metabolism
;
Glucose/metabolism
;
Hepatitis, Toxic/*diagnosis
;
Humans
;
Liver/drug effects
;
Liver Function Tests
;
Male
;
Middle Aged
;
Necrosis
5.A case of variceal bleeding from the jejunum in liver cirrhosis.
Chan Woong PARK ; Sae Hee KIM ; Hyeon Woong YANG ; Yun Jung LEE ; Sung Hee JUNG ; Ho Sup SONG ; Sang Ok LEE ; Anna KIM ; Sang Woo CHA
Clinical and Molecular Hepatology 2013;19(1):78-81
While esophagogastric varices are common manifestations of portal hypertension, variceal bleeding from the jejunum is a rare complication of liver cirrhosis. In addition, ectopic variceal bleeding occurs in the duodenum and at sites of previous bowel surgery in most cases, including of stomas. We report a case of obscure overt gastrointestinal bleeding from jejunal varices in a 55-year-old woman who had not previously undergone abdominal surgery, who had liver cirrhosis induced by the hepatitis C virus. Emergency endoscopy revealed the presence of esophageal varices without stigmata of recent bleeding, and no bleeding focus was found at colonoscopy. She continued to produce recurrent melena with hematochezia and received up to 21 units of packed red blood cells. CT angiography revealed the presence of jejunal varices, but no active bleeding was found. Capsule endoscopy revealed fresh blood in the jejunum. The patient submitted to embolization of the jejunal varices via the portal vein, after which she had a stable hemoglobin level and no recurrence of the melena. This is a case of variceal bleeding from the jejunum in a liver cirrhosis patient without a prior history of abdominal surgery.
Angiography
;
Capsule Endoscopy
;
Embolization, Therapeutic
;
Esophageal and Gastric Varices/complications/diagnosis
;
Female
;
*Gastrointestinal Hemorrhage
;
Humans
;
Hypertension, Portal
;
Jejunal Diseases/*diagnosis/therapy
;
Liver Cirrhosis/*diagnosis
;
Melena/complications
;
Middle Aged
;
Tomography, X-Ray Computed
6.Adenosquamous Carcinoma of Extrahepatic Bile Duct: A Case Report.
Sin Hyung LIM ; Hyeon Woong YANG ; Anna KIM ; Sang Woo CHA ; Sung Hee JUNG ; Hoon GO ; Woong Chul LEE
The Korean Journal of Internal Medicine 2007;22(3):206-210
Most malignant tumors originating from the biliary tract are adenocarcinomas, and adenosqamous carcinoma of Klatskin's tumor is a very rare finding. An 83-yr-old man was admitted to our hospital because of jaundice. The abdominal computed tomography and magnetic resonance cholangiopancreatography revealed wall thickening and luminal stenosis of both the intrahepatic duct confluent portion and the common hepatic duct. These findings were compatible with Klatskin's tumor, Bismuth type III. Considering the patient's old age, palliative combined modality therapy was performed. After percutaneous transhepatic biliary drainage, biopsy was performed via percutaneous transhepatic cholangioscopy. The histopathologic findings showed adenosquamous carcinoma. External radiotherapy and intraluminal brachytherapy through the endobiliary Y-type stent were then done. Nine months after the radiotherapy, the laboratory findings and the abdominal computed tomography revealed biliary obstruction and progressive hepatic metastasis. The combined modality therapy of external radiotherapy, intraluminal brachytherapy and stenting assisted him to live a normal life until he finally experienced biliary obstruction.
Aged, 80 and over
;
Bile Duct Neoplasms/*diagnosis/therapy
;
*Bile Ducts, Extrahepatic
;
Carcinoma, Adenosquamous/*diagnosis/therapy
;
Cholangiography
;
Combined Modality Therapy
;
Humans
;
Jaundice/etiology
;
Male
;
*Palliative Care
;
Stents
;
Tomography, X-Ray Computed
7.Brunnera's Gland Hyperplasia: Treatment of Severe Diffuse Nodular Hyperplasia Mimicking a Malignancy on Pancreatic-Duodenal Area.
Woong Chul LEE ; Hyeon Woong YANG ; Yun Jung LEE ; Sung Hee JUNG ; Gi Young CHOI ; Hoon GO ; Anna KIM ; Sang Woo CHA
Journal of Korean Medical Science 2008;23(3):540-543
Brunnera's gland hyperplasia is a benign tumor of the duodenum and it is rarely associated with clinical symptoms. We report on a 64-yr-old man with Brunnera's gland hyperplasia who had undergone a duodenocephalo-pancreatectomy. The reason is that he presented upper gastrointestinal obstructive symptoms and the esophagogastroduodenoscopic finding revealed the lesion to be an infiltrating type mass on the second portion of the duodenum with luminal narrowing. An abdominal computed tomography showed a 2.5 cm-sized mass in the duodenal second portion with a suspicious pancreatic invasion and 7 mm-sized lymph node around the duodenum. Duodenocephalopancreatectomy was successfully performed. Histological examination revealed a Brunnera's gland hyperplasia. The final diagnosis was the coexistence of Brunnera's gland hyperplasia and pancreatic heterotopia with a pancreatic head invasion. The literature on Brunnera's gland hyperplasia is reviewed.
Brunner Glands/*pathology/radiography
;
*Choristoma
;
Diagnosis, Differential
;
Duodenal Neoplasms/*pathology/radiography/surgery
;
Duodenum/pathology/radiography
;
Endoscopy, Gastrointestinal
;
Humans
;
Hyperplasia
;
Male
;
Middle Aged
;
Pancreatic Diseases/*pathology/radiography
;
Pancreaticoduodenectomy
;
Severity of Illness Index
;
Tomography, X-Ray Computed
8.A Case of Gastrointestinal Amyloidosis in Asymptomatic Multiple Myeloma.
Sae Hee KIM ; Yun Jung LEE ; Sung Hee JUNG ; Woo Jin HYEON ; Hyang Ie LEE ; Hyeon Woong YANG ; Anna KIM ; Sang Woo CHA ; Dong Wook KANG
Intestinal Research 2009;7(2):123-128
Amyloidosis is a disorder characterized by extracellular deposition of amyloid materials in multiple organs and tissues. Amyloidosis commonly shows a systemic involvement. Gastrointestinal involvement is common in amyloidosis and is usually asymptomatic. The gastrointestinal manifestations include gastroparesis, diarrhea, steatorrhea, constipation, intestinal pseudo-obstruction, and bleeding. The diagnosis of amyloidosis is difficult because there are absence of systemic symptoms and nonspecific endoscopic findings. Asymptomatic multiple myeloma is an asymptomatic plasma-cell proliferative disorder associated with a high risk of progression to symptomatic multiple myeloma or amyloidosis. Recently, we experienced a 60-year-old man who presented with hematochezia and weight loss as manifestations of gastrointestinal amyloidosis involving the stomach and the colon induced in asymptomatic multiple myeloma confirmed by endoscopic biopsies and bone marrow biopsy. We report a case with a review of the literature.
Amyloid
;
Amyloidosis
;
Biopsy
;
Bone Marrow
;
Colon
;
Constipation
;
Diarrhea
;
Gastrointestinal Hemorrhage
;
Gastroparesis
;
Hemorrhage
;
Humans
;
Intestinal Pseudo-Obstruction
;
Middle Aged
;
Multiple Myeloma
;
Steatorrhea
;
Stomach
;
Weight Loss
9.A Case of Gastrointestinal Amyloidosis in Asymptomatic Multiple Myeloma.
Sae Hee KIM ; Yun Jung LEE ; Sung Hee JUNG ; Woo Jin HYEON ; Hyang Ie LEE ; Hyeon Woong YANG ; Anna KIM ; Sang Woo CHA ; Dong Wook KANG
Intestinal Research 2009;7(2):123-128
Amyloidosis is a disorder characterized by extracellular deposition of amyloid materials in multiple organs and tissues. Amyloidosis commonly shows a systemic involvement. Gastrointestinal involvement is common in amyloidosis and is usually asymptomatic. The gastrointestinal manifestations include gastroparesis, diarrhea, steatorrhea, constipation, intestinal pseudo-obstruction, and bleeding. The diagnosis of amyloidosis is difficult because there are absence of systemic symptoms and nonspecific endoscopic findings. Asymptomatic multiple myeloma is an asymptomatic plasma-cell proliferative disorder associated with a high risk of progression to symptomatic multiple myeloma or amyloidosis. Recently, we experienced a 60-year-old man who presented with hematochezia and weight loss as manifestations of gastrointestinal amyloidosis involving the stomach and the colon induced in asymptomatic multiple myeloma confirmed by endoscopic biopsies and bone marrow biopsy. We report a case with a review of the literature.
Amyloid
;
Amyloidosis
;
Biopsy
;
Bone Marrow
;
Colon
;
Constipation
;
Diarrhea
;
Gastrointestinal Hemorrhage
;
Gastroparesis
;
Hemorrhage
;
Humans
;
Intestinal Pseudo-Obstruction
;
Middle Aged
;
Multiple Myeloma
;
Steatorrhea
;
Stomach
;
Weight Loss
10.The role of flexible sigmoidoscopy in the diagnosis of Clostridium difficile-associated diarrhea.
Sae Hee KIM ; Sung Hee JUNG ; Yun Jung LEE ; Woo Jin HYEON ; Young Wook YOO ; Hyang Ie LEE ; Hyeon Woong YANG ; Anna KIM ; Sang Woo CHA
Korean Journal of Medicine 2010;78(3):318-324
BACKGROUND/AIMS: Clostridium difficile is an important cause of diarrhea in hospitalized patients. C. difficile-associated diarrhea (CDAD) is usually diagnosed following a stool test for C. difficile cytotoxin or stool culture for the presence of toxigenic C. difficile. However, the reported sensitivities of these tests are variable. Sigmoidoscopy may be an effective diagnostic method in patients with a false-negative stool test for cytotoxin. This study examined the role of flexible sigmoidoscopy in the diagnosis of CDAD. METHODS: Among the patients who had diarrhea and were examined with sigmoidoscopy in Eulji University Hospital between January 2005 and July 2008, 102 patients suspected of having antibiotic-associated diarrhea (AAD) based on their clinical symptoms were enrolled. Of the 102 patients, 74 were diagnosed with CDAD based on C. difficile cytotoxin or sigmoidoscopic findings of pseudomembranous colitis. The medical records of these 74 patients were reviewed retrospectively. RESULTS: Of the 74 patients, sigmoidoscopic findings revealed a pseudomembrane in 63 patients (85.1%) and colitis in nine (12.2%), while two patients (2.7%) appeared normal. Of the 63 patients with pseudomembranous colitis at sigmoidoscopy, the stool C. difficile cytotoxin assay was negative in 27 (42.9%). CONCLUSIONS: Flexible sigmoidoscopy was highly sensitive in pseudomembranous colitis and is useful in diagnosing patients with a delayed or negative stool test for C. difficile cytotoxin. Therefore, we recommend flexible sigmoidoscopy in patients suspected of having C. difficile-associated diarrhea for the diagnosis of CDAD.
Clostridium
;
Clostridium difficile
;
Colitis
;
Diarrhea
;
Enterocolitis, Pseudomembranous
;
Humans
;
Medical Records
;
Sigmoidoscopy